Cargando…
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
Simon’s two-stage design and the admissible two-stage design have been commonly used in practice for single-arm phase II clinical trials when the primary endpoint is binary. The ethical benefit of the two-stage design over the single-stage design is attained by the early termination of the trial whe...
Autores principales: | Kim, Jongphil, Schell, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611508/ https://www.ncbi.nlm.nih.gov/pubmed/31303960 http://dx.doi.org/10.18632/oncotarget.26981 |
Ejemplares similares
-
Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
por: Qin, Fei, et al.
Publicado: (2020) -
Minimax and admissible adaptive two-stage designs in phase II clinical trials
por: Shan, Guogen, et al.
Publicado: (2016) -
An optimal stratified Simon two‐stage design
por: Parashar, Deepak, et al.
Publicado: (2016) -
H∞-optimal control and related: minimax design problems
por: Başar, Tamer, et al.
Publicado: (1991) -
Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design
por: Sampayo-Cordero, Miguel, et al.
Publicado: (2020)